Currently out of the existing stock ratings of Harry Goad, 25 are a BUY (56.82%), 15 are a HOLD (34.09%), 4 are a SELL (9.09%).
Analyst Harry Goad, currently employed at BERENBERG, has had 53.13% of price targets met with an average potential upside of 33.18%, reached in 351 days on average. Previously, Harry Goad worked at LIFESCI.
Harry Goad has documented 84 price targets and ratings displayed on 9 stocks. The coverage is on Basic Materials, Healthcare, Consumer Cyclical, Industrials sectors.
Most recent stock forecast was given on CRH, CRH PLC ADR at 19-Aug-2025.
Analyst best performing recommendations are on BZ (KANZHUN LTD ADR).
The best stock recommendation documented was for CX (CEMEX SAB DE CV ADR) on 5/19/2023. The price target of $6 was fulfilled within 4 days with a profit of $0.32 (5.06%), with a performance score of 12.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jul-2026
$107
$13.84 (14.86%)
$100
12 days ago
(06-Nov-2026)
0/12 (0%)
$12.19 (12.86%)
Buy Since 18-Jun-2024
$110
$16.84 (18.08%)
$105
15 days ago
(03-Nov-2026)
2/5 (40%)
$19.19 (21.13%)
130
Buy Since 09-Apr-2025
$114
$20.84 (22.37%)
$117
15 days ago
(03-Nov-2026)
2/6 (33.33%)
$23.19 (25.54%)
115
Buy Since 19-Oct-2023
$108
$14.84 (15.93%)
$106
15 days ago
(03-Nov-2026)
7/12 (58.33%)
$17.19 (18.93%)
177
Buy Since 14-Dec-2023
$120
$26.84 (28.81%)
$105
15 days ago
(03-Nov-2026)
5/9 (55.56%)
$29.19 (32.14%)
259
What Year was the first public recommendation made by Harry Goad?